Alere Spins Off Assets to Aid Abbott Merger

Alere Spins Off Assets to Aid Abbott Merger

by | Jul 21, 2017 1:55 pm | Laboratories, MRI & Dialysis, Medical Devices

Since February 2016, we’ve followed the testy merger between Abbott (NYSE: ABT) and Alere’s (NYSE: ALR) agreement to merge, followed by the respective lawsuits, and then the price renegotiation. Half way through 2017, the $5.3 billion deal is getting closer to completion, as Alere spins off some assets to comply with antitrust regulations. The first to go is Alere’s Triage® MeterPro cardiovascular (CV) and toxicology assets (“Triage business”), together with the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”). The buyer is  Quidel Corporation (NASDAQ: QDEL), which will acquire the Triage business, including real estate for the San... Read More »